INTEREST
Meeting category
Date(s)
24 Nov 2020 - 4 Dec 2020
Meeting type
Virtual

INTEREST 2020

Related Enduring Materials

Enduring Materials
Session 1 - Opening -
Impact of COVID-19 on HIV, Tuberculosis, and Malaria Epidemiology and Treatment Services Across Africa
John Nkengasong, PhD
U.S. President's Emergency Plan for AIDS Relief (PEPFAR), United States
HIV and Climate Change: the Research Opportunities
Matthew Chersich, MBBCh, MSc, PhD
University of the Witwatersrand, South Africa
Q&A - Session 1 - Opening
Oral Abstract Presentations 1 -
The Effect of Hazardous Drinking on Key HIV Outcomes among HIV-Positive Men: Results from Six Population-Based HIV Impact Assessments Completed in Sub-Saharan Africa (2015-2018)
Gregory Chang
#3
The Frequency and Yield of Cryptococcal Antigen Screening among Newly Diagnosed and Anti-Retroviral Therapy Experienced HIV Patients in Rural Uganda
Joseph Baluku
#4
Cost-Utility Analysis of Dolutegravir-Versus Efavirenz 400mg- Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon: 96-week Results from the NAMSAL ANRS 12313 Trial
Marwan al Qays Bousmah
#2
What Shapes Resilience Among People Living with HIV? A Multi- Country Analysis of Data from the PLHIV Stigma Index 2.0
Stella Kentusi
#1
Q&A - Oral Abstract Presentations 1

Day 2 - Tuesday, 1 December 2020

-
Session 2 -HIV Prevention
Nyaradzo Mavis Mgodi, MBChB, MMed
University of Zimbabwe Clinical Trials Research Centre, Zimbabwe
The ECHO Trial: What’s Next on Contraception and HIV: Policy, Practice, and Research?
Margaret Phiri Kasaro, MBChB, MSc
University of North Carolina Global Project Zambia (UNC GPZ), Zambia
Q&A - Session 2 - HIV Prevention
Mini-Oral Abstract Presentations 1 -
Striving Towards HIV Epidemic Control through Reaching a Population in Correctional Facilities in Namibia
Hilaria Ashivudhi
#26
Index-Linked HIV Testing for Children and Adolescents in Health Facility and Community-Based Settings in Zimbabwe: Findings from the B-GAP Study
Chido Dziva Chikwari
#24
Perceptions,Preferences and Access to Community-Based HIV Testing Services among Men who have Sex with Men (MSM) in Côte d’Ivoire
Maxime Inghels
#23
It is Better if you are Going to Test Yourself…”: Attitudes, Test Preferences and Challenges of HIV Self-Testing among Female Sex Workers in eThekwini, South Africa: the Siyaphanta study
Kedibone Sithole
#33
Traditional Healers Can Increase Uptake of HIV Testing among Adults of Unknown Serostatus: Results from a Cluster Randomized Pilot Study in Southwestern Uganda
Radhika Sundararajan
#37
A Gap Analysis and Total Quality Leadership and Accountability Intervention Triples HIV Testing Yield among Key Population in Zambia
Florence Tembo Mulenga
#18
Gaining Traction: Promising Shifts in Gender Norms and Intimate Partner Violence During an HIV prevention Trial in South Africa
Ann Gottert
#13
Case Series of Urethrocutaneous Fistulas After Voluntary Medical Male Circumcision for HIV Prevention—15 African Countries, 2015– 2019
Todd Lucas
#34
Is the Use of Creatinine Clearance Test at Baseline for PrEP Enrolment Necessary in Resource-Constrained Settings?
David Chilongozi
#15
Q&A - Mini-Oral Abstract Presentations 1

Day 3 - Wednesday, 2 December 2020

Oral Abstract Presentations 2 -
Monitoring and Management of Treatment Failure Among People on Antiretroviral Therapy in Mozambique: Lessons Learned to Improve Treatment Effectiveness
Laura Marcela Torres
#6
Rapid Antiretroviral Therapy Initiation and the Risk of Mortality and Loss to Follow-Up in Children with HIV
Peter James Elyanu
#7
High Levels of HIV Drug Resistance in Adult Patients with Unsuppressed Viral Load, Measured Through Routine Viral Load Programme Monitoring in South Africa, 2019
Gillian Hunt
#5
Effect of Same-Day ART Initiation on Early Retention in Rakai, Uganda
Jesca Basiima
#8
Q&A - Oral Abstract Presentations 2

Day 4 - Thursday, 3 December 2020

Session 3 - Access to Medicines and TB -
What you Need to Know about Public-Health Licensing and Access to Medicines in Africa
Sébastien Morin, PhD
Medicines Patent Pool, Switzerland
TB State-of-the-Art: Implications for Africa
Dereck Tait, MBChB
IAVI, South Africa
Q&A - Session 3 - Access to Medicines and TB
Mini-Oral Abstract Presentations 2 -
Current Approaches for Identifying and Managing HIV Treatment Failure Among Children, Adolescents, and Young People In Sub- Saharan Africa: Multi-Country Experience from the New Horizons Collaborative
Natella Rakhmanina
#36
Syndemic of Hepatitis B and C and Their Coinfection With HIV in Rwanda: Role of Unsafe Medical Practices and Sexual Behaviors
Jean Damascene Makuza
#17
Patient-Reported Outcomes After Direct-Acting Antiviral Treatment for Chronic Hepatitis C in West And Central Africa: The ANRS 12311 TAC Trial
Fabienne Marcellin
#14
Prevalence, Risk and Protective Factors for Common Mental Disorders Among Young People Living With HIV Compared to Their Uninfected Peers From the Kenyan Coast: A Cross Sectional Study
Moses Kachama Nyongesa
#29
Trends in Transmitted Drug Resistance in A Cohort Of ART-Naive HIV- 1 Infected Individuals in Ethiopia
Mulugeta Kiros
#16
Using A Quality Improvement Collaborative Approach to Improve Tuberculosis Prevention Therapy Coverage in The Kavango Region, Namibia
Apollo Basenero
#32
For Each Hour a Patient Living with HIV Spends in the Health Facility, the Probability of Being Retained in Care Decreases: Results from a Patients’ Satisfaction Survey in Mozambique
Caroline De Schacht
#12
Does Navigated Linkage to Care Work? A Cross-Sectional Study of Active Linkage to Care Within an Integrated Non-Communicable Disease
Kathryn Hopkins
#11
Q&A - Mini-Oral Abstract Presentations 2
Session 4 - STI and Implementation Science -
What’s New in Sexually Transmitted Infections and HIV in 2020
Rashida Ferrand, FRCP, PhD, FMed Sci
London School of Hygiene & Tropical Medicine, United Kingdom / Biomedical Research and Training Institute, Zimbabwe
Implementation Science - an African Perspective
Peter Cherutich, MBChB, PhD, MPH
Ministry of Health, Kenya
Q&A - Session 4 - STI and Implementation Science

Day 5 - Friday, 4 December 2020

Session 5 - Distance Learning and Dolutegravir Controversy -
Engaging in Collaborative Hands-On Learning: Building the Response in Africa
Leonard Bikinesi
Leonard Bikinesi, MD
Ministry of Health and Social Services, Namibia
Dolutegravir and Weight Gain - Where are We?
François Venter, MD, FCP, PhD
Ezintsha, University of the Witwatersrand, South Africa
Q&A - Session 5 - Distance Learning and Dolutegravir Controversy
Mini-Oral Abstract Presentations 3 -
Adverse Event Notification and Tracking Among HIV Positive Patients on ART: Lessons from A Tele-Health Centre In Kampala
Joram Okeng
#10
Creating a Safe Space for Key Populations Within Health Facilities: Experience from Montserrado County, Liberia
Gift Kamanga
#9
Stakeholder Participation in The Establishment of One-Stop Shops and Key Population-Friendly Facilities: Descriptive Lessons from the FHI 360 GF Project
Chidubem Oraelosi
#27
Incident HIV Infection Among Pregnant Women in The South African 2017 Antenatal Survey: Assay-Based Incidence Measurement
Selamawit Woldesenbet
#20
Cost of Antiretroviral Therapy Services Among Patients Who Achieved Viral Suppression: A Case Study Of 9 ART Clinics in Namibia
Ndapewa Hamunime
#31
Alarming Burden of Dual-Class HIV-1 Drug Resistance Among Adolescents Calls for Innovative Antiretroviral Strategies: Baseline Findings from the Ready-Study (EDCTP TMA 1027)
Armanda Nangmo
#25
Positive Effects of Intensified Preventive Calls/Home Visits on Early Retention Among Adults Newly Initiated on Antiretroviral Therapy in Zambézia Province, Mozambique
José Tique
#38
Short-Cycle Therapy in HIV-Infected Adults: 4 days on / 3 days off with Combinations Containing Rilpivirine
Dora Luise
#22
Transcriptional Analysis of Lymph Node Derived Follicular CD4 T Cells Reveal Novel Phenotypic Markers and Functions of T Follicular Regulatory (TFR) Cells
Bongiwe Mahlobo
#21
Q&A - Mini-Oral Abstract Presentations 3
IAS Session - Getting to the Heart of Stigma: What does it take to have an impact at scale?
PRE-WEEK - INTEREST 2020 -
ViiV - Exploring the Basics of Implementation Science in HIV
Grantspersonship NIADS/NIH/Fogarty
Peter Kilmarx, MD, FACP, FIDSA
John E. Fogarty International Center, National Institutes of Health, USA
JIAS - Session: How to write and submit a research manuscript: “publish or perish”
Marlène Bras
JIAS Executive Editor
Ann Grimsrud
JIAS Deputy Editor
Language